DIRECTOR, CENTER FOR STEM CELL AND TRANSLATIONAL IMMUNOTHERAPY, BRIGHAM AND WOMEN'S HOSPITAL
BIOGRAPHY
NOV 16, 2022 7:00 PM PST
Innovation in Science and Technology: Translating Cellular Therapies from Bench to Bedside
Speakers
Event Date & Time
Date: November 16, 2022
Time:7:00pm (PST), 10:00pm (EST), 4:00am (CET)
Abstract
Date: November 17, 2022
2:00pm (AEST)
The growth in FDA-approved cell and gene therapy products for the treatment of diseases including cancer is rapid. However, due to the complexity of cancer biology and manufacturing novelties, there are many challenges in developing and producing regenerative medicines.
In this webinar, Dr. Khalid Shah, MS, Ph.D. Vice-Chair of Research Neurosurgery, from BWH, Harvard Medical School, will present strategies for effective development of cellular therapies via gene editing. He will also discuss how to develop and validate relevant tumor models to ensure the clinical translation of therapeutic cells.
In addition, Dr. Jean Qiu, Founder and Chief Technology Officer of Nexcelom Bioscience, will describe how to enable novel technologies for standardizing cell counting and other critical quality attributes throughout the entire regenerative medicine development process.
Learning Objectives
- Apply multiple approaches in gene editing and engineering of cells to develop cellular therapies
- Build and evaluate relevant tumor models for effective transition from basic research to clinical trial
- Enable novel technology to apply ISO standards for developing regenerative medicines
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...